Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Shaw

Showing results (1-10 of 449) with videos related to

Pageof 45
Sort By:
Diabetes Care|October 21, 2021
Paul Zimmet: A Voice for DiabetesJonathan E Shaw
Therapeutic Advances in Endocrinology and Metabolism|July 20, 2019
Prediabetes: lifestyle, pharmacotherapy or regulation?Jonathan E Shaw
Diabetologia|August 24, 2017
Does the evidence support population-wide screening for type 2 diabetes? NoJonathan E Shaw
Evidence-Based Medicine|November 23, 2011
Intensive glucose lowering (HbA1c target<6.0%) for people with type 2 diabetes increases mortalityJonathan E Shaw
American Journal of Preventive Medicine|September 22, 2022
We Need Lifestyle Modification Trials for the Reversal of Impaired Fasting GlucoseThirunavukkarasu Sathish, Jonathan E Shaw
JAMA Ophthalmology|December 5, 2024
Diabetic Retinopathy-Another Possible Target for SGLT2 Inhibitors?Jonathan E Shaw, Alicia J Jenkins
The New England Journal of Medicine|August 21, 2024
Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor AgonistsJoanna Y Gong, Jonathan E Shaw
Journal of Diabetes|September 12, 2014
Individualizing therapy: do we have the tools to do it?Jonathan E Shaw, Zachary T Bloomgarden
The New England Journal of Medicine|June 13, 2017
Global Health Effects of Overweight and ObesityEdward W Gregg, Jonathan E Shaw
The Medical Journal of Australia|November 2, 2019
Inpatient diabetes care requires adequate support, not just HbA<sub>1c</sub> screeningMatthew Jl Hare, Jonathan E Shaw
Pageof 45

Showing results (1-10 of 449) with videos related to

Sort By:
Pageof 45
Diabetes Care|October 21, 2021
Paul Zimmet: A Voice for DiabetesJonathan E Shaw
Therapeutic Advances in Endocrinology and Metabolism|July 20, 2019
Prediabetes: lifestyle, pharmacotherapy or regulation?Jonathan E Shaw
Diabetologia|August 24, 2017
Does the evidence support population-wide screening for type 2 diabetes? NoJonathan E Shaw
Evidence-Based Medicine|November 23, 2011
Intensive glucose lowering (HbA1c target<6.0%) for people with type 2 diabetes increases mortalityJonathan E Shaw
American Journal of Preventive Medicine|September 22, 2022
We Need Lifestyle Modification Trials for the Reversal of Impaired Fasting GlucoseThirunavukkarasu Sathish, Jonathan E Shaw
JAMA Ophthalmology|December 5, 2024
Diabetic Retinopathy-Another Possible Target for SGLT2 Inhibitors?Jonathan E Shaw, Alicia J Jenkins
The New England Journal of Medicine|August 21, 2024
Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor AgonistsJoanna Y Gong, Jonathan E Shaw
Journal of Diabetes|September 12, 2014
Individualizing therapy: do we have the tools to do it?Jonathan E Shaw, Zachary T Bloomgarden
The New England Journal of Medicine|June 13, 2017
Global Health Effects of Overweight and ObesityEdward W Gregg, Jonathan E Shaw
The Medical Journal of Australia|November 2, 2019
Inpatient diabetes care requires adequate support, not just HbA<sub>1c</sub> screeningMatthew Jl Hare, Jonathan E Shaw
Pageof 45